Eldar Davletshin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eldar Davletshin has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Darya A. Nedopekina
Institute of Petrochemistry and Catalysis, Ufa Federal Research Center, Russian Academy of Sciences, 141 Prospekt Oktyabrya, 450075 Ufa, Russia
9 shared publications - Anna Yu. Spivak
Institute of Petrochemistry and Catalysis, Ufa Federal Research Center, Russian Academy of Sciences, Ufa, Russia
8 shared publications - Konstantin N. Belosludtsev
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Russia
4 shared publications - Mikhail V. Dubinin
Mari State University, Yoshkar-Ola, Russia
4 shared publications - Alena A. Semenova
Department of Biochemistry, Cell Biology, and Microbiology, Mari State University, Yoshkar-Ola, 424001, Russia
2 shared publications - Anna I. Ilzorkina
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Institutskaya 3, 142290 Pushchino, Russia
2 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by MDPI AG in Chemistry Proceedings
- Vol. 22 (1) , 5
Synthesis of Novel Mitochondria-Targeted Tranilast Derivatives with a Triphenylphosphonium Fragment in the Side Chain Exhibiting Enhanced In Vitro Antitumor Activity
N-3,4-dimethoxycinnamoylanthranilic acid (the active ingredient in tranilast) is an amide of anthranilic acid and 3,4-dimethoxycinnamic acid. This drug has been used in Japan and South Korea since 1982 for the treatment of bronchial asthma. Subsequent studies have shown that tranilast is effective in treating a wide range of diseases, including fibrosis, proliferative disorders, and autoimmune diseases, and exhibits promising antitumor activity. However, its clinical application is limited by low bioavailability and non-selective cellular localization. As a promising approach to overcome these drawbacks, we conjugated tranilast with the lipophilic cation triphenylphosphonium (TPP+), which enables targeted delivery of the compound to mitochondria, the main source of reactive oxygen species. We have developed an efficient method for the synthesis of two previously unknown amide derivatives of tranilast bearing a TPP+ group in the side chain linked via C-6 alkyl or dipeptide linkers. The synthesis involved amidation of tranilast with aminohexanol, mesylation of the terminal hydroxyl group, and conversion of the mesylate to a bromide or azide by reaction with LiBr or NaN3. The bromoalkyl derivative of tranilast was transformed into a TPP+ conjugate by reaction with triphenylphosphine. The azide derivative was preliminarily reduced to an amine using PPh3 and conjugated with the triphenylphosphonium salt of pentanoic acid. The structures were confirmed by 1D and 2D NMR spectroscopy. Cytotoxic activity was studied in vitro against five human cancer cell lines (MCF-7, A549, K562, MDA-MB-231, SH-SY5Y) and normal HEK293T cells. Tranilast was found to be devoid of cytotoxicity (IC50 > 100 μM), while its TPP+ derivatives demonstrated antitumor activity against all tested cell lines in the low micromolar range (IC50 = 4.58–15.66 μM).
- 9 October 2026
- Published by MDPI AG in Chemistry Proceedings
- Vol. 22 (1) , 5
Open AccessSynthesis of Novel Mitochondria-Targeted Tranilast Derivatives with a Triphenylphosphonium Fragment in the Side Chain Exhibiting Enhanced In Vitro Antitumor Activity
N-3,4-dimethoxycinnamoylanthranilic acid (the active ingredient in tranilast) is an amide of anthranilic acid and 3,4-dimethoxycinnamic acid. This drug has been used in Japan and South Korea since 1982 for the treatment of bronchial asthma. Subsequent studies have shown that tranilast is effective in treating a wide range of diseases, including fibrosis, proliferative disorders, and autoimmune diseases, and exhibits promising antitumor activity. However, its clinical application is limited by low bioavailability and non-selective cellular localization. As a promising approach to overcome these drawbacks, we conjugated tranilast with the lipophilic cation triphenylphosphonium (TPP+), which enables targeted delivery of the compound to mitochondria, the main source of reactive oxygen species. We have developed an efficient method for the synthesis of two previously unknown amide derivatives of tranilast bearing a TPP+ group in the side chain linked via C-6 alkyl or dipeptide linkers. The synthesis involved amidation of tranilast with aminohexanol, mesylation of the terminal hydroxyl group, and conversion of the mesylate to a bromide or azide by reaction with LiBr or NaN3. The bromoalkyl derivative of tranilast was transformed into a TPP+ conjugate by reaction with triphenylphosphine. The azide derivative was preliminarily reduced to an amine using PPh3 and conjugated with the triphenylphosphonium salt of pentanoic acid. The structures were confirmed by 1D and 2D NMR spectroscopy. Cytotoxic activity was studied in vitro against five human cancer cell lines (MCF-7, A549, K562, MDA-MB-231, SH-SY5Y) and normal HEK293T cells. Tranilast was found to be devoid of cytotoxicity (IC50 > 100 μM), while its TPP+ derivatives demonstrated antitumor activity against all tested cell lines in the low micromolar range (IC50 = 4.58–15.66 μM).
- 1 June 2025
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 95 (6) , 1494-1500
Efficient and Practical Synthesis of a Novel Lipophilic Phenothiazine Derivative with an α-Tocopherol Isoprenoid Side Chain
A method was developed for the synthesis of a new amide derivative of phenothiazine containing a (4RS,8RS)-4,8,12-trimethyltridecane chain identical to the phytyl isoprenoid chain of racemic α-tocopherol. The phenothiazine analogue of alpha-tocopherol was obtained by coupling of 2-aminophenothiazine with (4RS,8RS)-4,8,12-trimethyltridecanoic acid. The main features of its synthesis were the Bayer–Villiger oxidation of phytone under the action of a household oxidant based on sodium percarbonate “O2Clean” and the environmentally friendly aerobic oxidation protocol of (4RS,8RS)-4,8,12-trimethyltridecanole with oxygen using the iron-containing catalyst Fe(NO3)3·9H2O–TEMPO–KCl.
- 1 June 2025
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 95 (6) , 1494-1500
Efficient and Practical Synthesis of a Novel Lipophilic Phenothiazine Derivative with an α-Tocopherol Isoprenoid Side Chain
A method was developed for the synthesis of a new amide derivative of phenothiazine containing a (4RS,8RS)-4,8,12-trimethyltridecane chain identical to the phytyl isoprenoid chain of racemic α-tocopherol. The phenothiazine analogue of alpha-tocopherol was obtained by coupling of 2-aminophenothiazine with (4RS,8RS)-4,8,12-trimethyltridecanoic acid. The main features of its synthesis were the Bayer–Villiger oxidation of phytone under the action of a household oxidant based on sodium percarbonate “O2Clean” and the environmentally friendly aerobic oxidation protocol of (4RS,8RS)-4,8,12-trimethyltridecanole with oxygen using the iron-containing catalyst Fe(NO3)3·9H2O–TEMPO–KCl.
- Open Access
- 15 November 2023
- Published by MDPI AG in Chemistry Proceedings
- Vol. 14 (1) , 49
Phenothiazine Conjugate with Mitochondria-Directed Cationic Compound F16: Synthesis and Cytotoxic Action against Human Breast Carcinoma
The development of new drugs or drug candidates based on the phenothiazine system (10H-dibenzo-[b,e]-1,4-thiazine) is a promising approach in view of the diverse biological activity of this tricyclic system, which is present in traditional drugs (chlorpromazine, thioridazine, trifluoperazine, and trifluopromazine) with antipsychotropic, antihistamine and antimuscarinic activities. In practical medicine, these drugs are used as antagonists of dopamine and other neurotransmitter receptors for the treatment of schizophrenia and bipolar disorders. Ongoing studies on the synthesis and biological screening of various phenothiazine derivatives in recent years have revealed other important biological effects of these compounds, among which their antitumor effects are of great interest. This work reports the synthesis of a novel N-substituted phenothiazine analog bearing a mitochondria-directed cationic group (E)-4-(1H-indol-3-ylvinyl)-pyridinium (F16) linked to the nitrogen atom of the phenothiazine core by a butane bridge. The lipophilic cationic F16 fragment was used as a means to enhance transmembrane transport and selective delivery of the hybrid molecule into the mitochondria of cancer cells. In tests on the BT474 breast cancer cell line, the phenothiazine-F16 hybrid demonstrated significant cytotoxic activity. The cytotoxic effect of the compound was noticeable at a concentration of 5 μM and further increased dose-dependently, leading to complete tumor cell death at a concentration of 50 μM (IC50 3.3 μM). The F16-derivative of phenotzine showed marked mitochondrial targeting. In experiments on isolated rat liver mitochondria, the tested agent, already at a concentration of 5 μM, significantly decreased the membrane potential of succinate-energized organelles. Increasing the concentration of the phenothiazine hybrid to 20 μM resulted in complete dissipation of the potential. The obtained result of antitumor activity against BT-474 cell culture and significant effect on the reduction of mitochondrial membrane potential allows us to consider phenothiazine-F16 hybrid as a new promising antitumor drug.
- 15 November 2023
- Published by MDPI AG in Chemistry Proceedings
- Vol. 14 (1) , 49
Open AccessPhenothiazine Conjugate with Mitochondria-Directed Cationic Compound F16: Synthesis and Cytotoxic Action against Human Breast Carcinoma
The development of new drugs or drug candidates based on the phenothiazine system (10H-dibenzo-[b,e]-1,4-thiazine) is a promising approach in view of the diverse biological activity of this tricyclic system, which is present in traditional drugs (chlorpromazine, thioridazine, trifluoperazine, and trifluopromazine) with antipsychotropic, antihistamine and antimuscarinic activities. In practical medicine, these drugs are used as antagonists of dopamine and other neurotransmitter receptors for the treatment of schizophrenia and bipolar disorders. Ongoing studies on the synthesis and biological screening of various phenothiazine derivatives in recent years have revealed other important biological effects of these compounds, among which their antitumor effects are of great interest. This work reports the synthesis of a novel N-substituted phenothiazine analog bearing a mitochondria-directed cationic group (E)-4-(1H-indol-3-ylvinyl)-pyridinium (F16) linked to the nitrogen atom of the phenothiazine core by a butane bridge. The lipophilic cationic F16 fragment was used as a means to enhance transmembrane transport and selective delivery of the hybrid molecule into the mitochondria of cancer cells. In tests on the BT474 breast cancer cell line, the phenothiazine-F16 hybrid demonstrated significant cytotoxic activity. The cytotoxic effect of the compound was noticeable at a concentration of 5 μM and further increased dose-dependently, leading to complete tumor cell death at a concentration of 50 μM (IC50 3.3 μM). The F16-derivative of phenotzine showed marked mitochondrial targeting. In experiments on isolated rat liver mitochondria, the tested agent, already at a concentration of 5 μM, significantly decreased the membrane potential of succinate-energized organelles. Increasing the concentration of the phenothiazine hybrid to 20 μM resulted in complete dissipation of the potential. The obtained result of antitumor activity against BT-474 cell culture and significant effect on the reduction of mitochondrial membrane potential allows us to consider phenothiazine-F16 hybrid as a new promising antitumor drug.
- Open Access
- 15 November 2023
- Published by MDPI AG in Chemistry Proceedings
- Vol. 14 (1) , 43
Synthesis and Cytotoxic Activity of Conjugates of Mitochondrial-Directed Cationic Compound F16 with Ursane-Structure Triterpenic Acids Containing a Polyhydroxylated A-ring
We chemically linked corosolic and asiatic acids and a synthetic polyoxygenated analogue of ursolic acid via an alkyl linker to the cationic mitochondrial targeting compound F16 (4-(1H-indole-3-ylvinyl)-N-methylpyridinium iodide). The conjugates were tested for cytotoxic activity against two human lung adenocarcinoma cell lines, H1299 and A549, and non-cancerous mouse embryonic fibroblast cells. The results showed that conjugation of polyoxygenated triterpene acids with the terminal cationic fragment F16 in the C-28 side chain enhanced cytotoxicity (30–35 fold) compared to the original natural ursolic acid. However, the presence of hydroxyl or acetyl functions in the A-ring of F16 conjugates of corosolic or asiatic acids resulted in a significant decrease in cytotoxicity compared to their structural analogue, the F16 derivative of ursolic acid.
- 15 November 2023
- Published by MDPI AG in Chemistry Proceedings
- Vol. 14 (1) , 43
Open AccessSynthesis and Cytotoxic Activity of Conjugates of Mitochondrial-Directed Cationic Compound F16 with Ursane-Structure Triterpenic Acids Containing a Polyhydroxylated A-ring
We chemically linked corosolic and asiatic acids and a synthetic polyoxygenated analogue of ursolic acid via an alkyl linker to the cationic mitochondrial targeting compound F16 (4-(1H-indole-3-ylvinyl)-N-methylpyridinium iodide). The conjugates were tested for cytotoxic activity against two human lung adenocarcinoma cell lines, H1299 and A549, and non-cancerous mouse embryonic fibroblast cells. The results showed that conjugation of polyoxygenated triterpene acids with the terminal cationic fragment F16 in the C-28 side chain enhanced cytotoxicity (30–35 fold) compared to the original natural ursolic acid. However, the presence of hydroxyl or acetyl functions in the A-ring of F16 conjugates of corosolic or asiatic acids resulted in a significant decrease in cytotoxicity compared to their structural analogue, the F16 derivative of ursolic acid.
- Open Access
Conjugation of Triterpenic Acids of Ursane and Oleanane Types with Mitochondria-Targeting Cation F16 Synergistically Enhanced Their Cytotoxicity against Tumor Cells
The present work shows the cytotoxic effects of novel conjugates of ursolic, oleanolic, maslinic, and corosolic acids with the penetrating cation F16 on cancer cells (lung adenocarcinoma A549 and H1299, breast cancer cell lines MCF-7 and BT474) and non-tumor human fibroblasts. It has been established that the conjugates have a significantly enhanced toxicity against tumor-derived cells compared to native acids and also demonstrate selectivity to some cancer cells. The toxic effect of the conjugates is shown to be due to ROS hyperproduction in cells, induced by the effect on mitochondria. The conjugates caused dysfunction of isolated rat liver mitochondria and, in particular, a decrease in the efficiency of oxidative phosphorylation, a decrease in the membrane potential, and also an overproduction of ROS by organelles. The paper discusses how the membranotropic- and mitochondria-targeted effects of the conjugates may be related to their toxic effects.
Open AccessConjugation of Triterpenic Acids of Ursane and Oleanane Types with Mitochondria-Targeting Cation F16 Synergistically Enhanced Their Cytotoxicity against Tumor Cells
The present work shows the cytotoxic effects of novel conjugates of ursolic, oleanolic, maslinic, and corosolic acids with the penetrating cation F16 on cancer cells (lung adenocarcinoma A549 and H1299, breast cancer cell lines MCF-7 and BT474) and non-tumor human fibroblasts. It has been established that the conjugates have a significantly enhanced toxicity against tumor-derived cells compared to native acids and also demonstrate selectivity to some cancer cells. The toxic effect of the conjugates is shown to be due to ROS hyperproduction in cells, induced by the effect on mitochondria. The conjugates caused dysfunction of isolated rat liver mitochondria and, in particular, a decrease in the efficiency of oxidative phosphorylation, a decrease in the membrane potential, and also an overproduction of ROS by organelles. The paper discusses how the membranotropic- and mitochondria-targeted effects of the conjugates may be related to their toxic effects.
- Open Access
- 11 November 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (11) , 2903
Comparative Study of Cytotoxic and Membranotropic Properties of Betulinic Acid-F16 Conjugate on Breast Adenocarcinoma Cells (MCF-7) and Primary Human Fibroblasts
The present study evaluates the cytotoxicity of a previously synthesized conjugate of betulinic acid (BA) with the penetrating cation F16 on breast adenocarcinoma (MCF-7) and human fibroblast (HF) cell lines, and also shows the mechanism underlying its membranotropic action. It was confirmed that the conjugate exhibits higher cytotoxicity compared to native BA at low doses also blocking the proliferation of both cell lines and causing cell cycle arrest in the G0/G1 phase. We show that the conjugate indeed has a high potential for accumulation in mitochondria, being visualized in these organelles, which is most pronounced in cancer cells. The effect of the conjugate was observed to be accompanied by ROS hyperproduction in both cancerous and healthy cells, despite the lower base level of ROS in the latter. Along with this, using artificial liposomes, we determined that the conjugate is able to influence the phase state of lipid membranes, make them more fluid, and induce nonspecific permeabilization contributing to the overall cytotoxicity of the tested agent. We conclude that the studied BA–F16 conjugate does not have significant selective cytotoxicity, at least against the studied breast cancer cell line MCF-7.
- 11 November 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (11) , 2903
Open AccessComparative Study of Cytotoxic and Membranotropic Properties of Betulinic Acid-F16 Conjugate on Breast Adenocarcinoma Cells (MCF-7) and Primary Human Fibroblasts
The present study evaluates the cytotoxicity of a previously synthesized conjugate of betulinic acid (BA) with the penetrating cation F16 on breast adenocarcinoma (MCF-7) and human fibroblast (HF) cell lines, and also shows the mechanism underlying its membranotropic action. It was confirmed that the conjugate exhibits higher cytotoxicity compared to native BA at low doses also blocking the proliferation of both cell lines and causing cell cycle arrest in the G0/G1 phase. We show that the conjugate indeed has a high potential for accumulation in mitochondria, being visualized in these organelles, which is most pronounced in cancer cells. The effect of the conjugate was observed to be accompanied by ROS hyperproduction in both cancerous and healthy cells, despite the lower base level of ROS in the latter. Along with this, using artificial liposomes, we determined that the conjugate is able to influence the phase state of lipid membranes, make them more fluid, and induce nonspecific permeabilization contributing to the overall cytotoxicity of the tested agent. We conclude that the studied BA–F16 conjugate does not have significant selective cytotoxicity, at least against the studied breast cancer cell line MCF-7.
- Open Access
- 12 November 2021
- Published by MDPI AG in Chemistry Proceedings
- Vol. 8 (1) , 97
Effective Synthesis of a Novel Betulinic Acid Conjugate with Mitochondria-Targeting Cation F16
Currently, mitochondria are considered as an attractive universal target in the development of new anticancer drugs. These organelles are essential in energy production, the regulation of cell death pathways, the generation of reactive oxygen species, as well as in the maintenance of calcium homeostasis. Various approaches are being developed to deliver biologically active compounds into the mitochondria of tumour cells, including the conjugation of cytotoxic substances with mitochondria-targeted lipophilic cations. Among the currently known low molecular weight lipophilic cationic molecules, (E)-4(1H-indol-3-ylvinyl)-N-methylpyridinium iodide (F16) is of great interest. This mitochondria-toxic cationic compound with luminescent properties is selectively accumulated in mitochondria and can selectively trigger the apoptosis and necrosis of tumour cells, making it an attractive targeted agent for theranostic use. Meanwhile, betulinic acid, an available natural pentacyclic triterpenoid, has been considered as a promising scaffold for the development of new anticancer agents in recent years. The antitumour effect of this natural product arises from it affecting the mitochondria of tumour cells through the formation of reactive oxygen species. The present article details of an efficient synthesis of a novel multifunctional hybrid agent in which a cytotoxic triterpenoid, betulinic acid, is carbon-carbon bonded to the cationic F16 fragment at the C-2 position of ring A through a phenylethynyl spacer. The starting substrates in the synthesis were the C-2 propynyl derivative of betulinic acid and N-aryl-substituted 4-(1H-indol-3-ylvinyl)-pyridine. The derivative of betulinic acid with a terminal acetylenic group was prepared by the reaction of C-alkylation with propargyl bromide of potassium enoxytriethylborate generated from betulonic acid. To obtain the N-aryl-substituted analogue of F16, a CuI-catalyzed Ullmann-Goldberg reaction was applied. The synthesis of the target conjugate was successfully completed by the cross-coupling of the terpene and heterocyclic components according to Sonogashira in the presence of the CuI/Pd(PPh3)2 catalyst.
- 12 November 2021
- Published by MDPI AG in Chemistry Proceedings
- Vol. 8 (1) , 97
Open AccessEffective Synthesis of a Novel Betulinic Acid Conjugate with Mitochondria-Targeting Cation F16
Currently, mitochondria are considered as an attractive universal target in the development of new anticancer drugs. These organelles are essential in energy production, the regulation of cell death pathways, the generation of reactive oxygen species, as well as in the maintenance of calcium homeostasis. Various approaches are being developed to deliver biologically active compounds into the mitochondria of tumour cells, including the conjugation of cytotoxic substances with mitochondria-targeted lipophilic cations. Among the currently known low molecular weight lipophilic cationic molecules, (E)-4(1H-indol-3-ylvinyl)-N-methylpyridinium iodide (F16) is of great interest. This mitochondria-toxic cationic compound with luminescent properties is selectively accumulated in mitochondria and can selectively trigger the apoptosis and necrosis of tumour cells, making it an attractive targeted agent for theranostic use. Meanwhile, betulinic acid, an available natural pentacyclic triterpenoid, has been considered as a promising scaffold for the development of new anticancer agents in recent years. The antitumour effect of this natural product arises from it affecting the mitochondria of tumour cells through the formation of reactive oxygen species. The present article details of an efficient synthesis of a novel multifunctional hybrid agent in which a cytotoxic triterpenoid, betulinic acid, is carbon-carbon bonded to the cationic F16 fragment at the C-2 position of ring A through a phenylethynyl spacer. The starting substrates in the synthesis were the C-2 propynyl derivative of betulinic acid and N-aryl-substituted 4-(1H-indol-3-ylvinyl)-pyridine. The derivative of betulinic acid with a terminal acetylenic group was prepared by the reaction of C-alkylation with propargyl bromide of potassium enoxytriethylborate generated from betulonic acid. To obtain the N-aryl-substituted analogue of F16, a CuI-catalyzed Ullmann-Goldberg reaction was applied. The synthesis of the target conjugate was successfully completed by the cross-coupling of the terpene and heterocyclic components according to Sonogashira in the presence of the CuI/Pd(PPh3)2 catalyst.
- Open Access
Effect of F16-Betulin Conjugate on Mitochondrial Membranes and Its Role in Cell Death Initiation
This work demonstrates the effects of a newly synthesized conjugate of the plant triterpenoid betulin and the penetrating cation F16 used for mitochondrial targeting. The resulting F16-betulin conjugate revealed a mitochondria-targeted effect, decreasing the mitochondrial potential and inducing superoxide overproduction in rat thymocytes in vitro. It has been suggested that this may cause the cytotoxic effect of the conjugate, which significantly exceeds the effectiveness of its precursors, betulin and F16. Using isolated rat liver mitochondria, we found that the F16-betulin conjugate has a surface-active effect on mitochondrial membranes, causing organelle aggregation. This effect of the derivative resulted in a dose-dependent decrease in mitochondrial transmembrane potential, as well as suppression of respiration and oxidative phosphorylation, especially in the case of nicotinamide adenine dinucleotide (NAD)-fueled organelles. In addition, the F16-betulin conjugate caused an increase in H2O2 generation by mitochondria fueled with glutamate and malate. These effects of the derivative can presumably be due to the powerful suppression of the redox activity of complex I of the mitochondrial electron transport chain. The paper discusses how the mitochondria-targeted effects of the F16-betulin conjugate may be related to its cytotoxic effects.
Open AccessEffect of F16-Betulin Conjugate on Mitochondrial Membranes and Its Role in Cell Death Initiation
This work demonstrates the effects of a newly synthesized conjugate of the plant triterpenoid betulin and the penetrating cation F16 used for mitochondrial targeting. The resulting F16-betulin conjugate revealed a mitochondria-targeted effect, decreasing the mitochondrial potential and inducing superoxide overproduction in rat thymocytes in vitro. It has been suggested that this may cause the cytotoxic effect of the conjugate, which significantly exceeds the effectiveness of its precursors, betulin and F16. Using isolated rat liver mitochondria, we found that the F16-betulin conjugate has a surface-active effect on mitochondrial membranes, causing organelle aggregation. This effect of the derivative resulted in a dose-dependent decrease in mitochondrial transmembrane potential, as well as suppression of respiration and oxidative phosphorylation, especially in the case of nicotinamide adenine dinucleotide (NAD)-fueled organelles. In addition, the F16-betulin conjugate caused an increase in H2O2 generation by mitochondria fueled with glutamate and malate. These effects of the derivative can presumably be due to the powerful suppression of the redox activity of complex I of the mitochondrial electron transport chain. The paper discusses how the mitochondria-targeted effects of the F16-betulin conjugate may be related to its cytotoxic effects.
- Open Access
- 13 November 2020
- Published by MDPI AG in Chemistry Proceedings
- Vol. 3 (1) , 11
Design, Synthesis, and Photophysical Properties of BODIPY-Labeled Lupane Triterpenoids
Novel boron-dipyrromethene difluoride (4,4-difluoro-4-bora-3α,4α-diaza-s-indacene) (BODIPY)-lupane triterpenoid conjugates bearing a fluorescent marker at the C-2 position of ring A of the triterpene core were obtained via the Sonogashira reaction as a key step. The starting compounds in the cross-coupling reaction were C-2 propynyl derivatives of betulinic or betulonic acids and fluorescent dyes with an iodo-group at C-2 or meso position of BODIPY-platform. The newly elaborated coupling procedure might have applicability in the synthesis of fluorescently-labeled triterpenoid conjugates suitable for biological assays.
- 13 November 2020
- Published by MDPI AG in Chemistry Proceedings
- Vol. 3 (1) , 11
Open AccessDesign, Synthesis, and Photophysical Properties of BODIPY-Labeled Lupane Triterpenoids
Novel boron-dipyrromethene difluoride (4,4-difluoro-4-bora-3α,4α-diaza-s-indacene) (BODIPY)-lupane triterpenoid conjugates bearing a fluorescent marker at the C-2 position of ring A of the triterpene core were obtained via the Sonogashira reaction as a key step. The starting compounds in the cross-coupling reaction were C-2 propynyl derivatives of betulinic or betulonic acids and fluorescent dyes with an iodo-group at C-2 or meso position of BODIPY-platform. The newly elaborated coupling procedure might have applicability in the synthesis of fluorescently-labeled triterpenoid conjugates suitable for biological assays.